Patent Expiry
ZVRA: APADAZ: recorded patent 8461137 expiry
February 22, 2031 · ACETAMINOPHEN; BENZHYDROCODONE HYDROCHLORIDE. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- February 22, 2031
- Company
- ZEVRA THERAPEUTICS, INC. (ZVRA)
- Drug
- ACETAMINOPHEN; BENZHYDROCODONE HYDROCHLORIDE
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Patent Expiry
APADAZ: recorded patent 8461137 expiry
Orange Book application NDA208653, product 002, listed patent 8461137 expiry. Overall loss of exclusivity and current company rights: unknown.FDA source
- Drug
- ACETAMINOPHEN; BENZHYDROCODONE HYDROCHLORIDE